News

Patients with severe asthma who initiate biologics may reduce their risk for oral corticosteroids (OCS)-related new-onset adverse outcomes.
Scientists have identified gut lining cells as active participants in triggering celiac disease, marking a breakthrough that ...
Competition from Amgen's romosozumab and patient preference for subcutaneous administration threaten setrusumab’s potential ...
Adult and pediatric patients with classic congenital adrenal hyperplasia treated with CRENESSITY® (crinecerfont) achieved clinically meaningful weight reductions ...
Adult and pediatric patients with classic congenital adrenal hyperplasia treated with CRENESSITY® (crinecerfont) achieved clin ...